title: Pegaptanib sodium.
authors.forename: Stuart L
authors.initials: SL
authors.lastname: Fine
authors.forename: Daniel F
authors.initials: DF
authors.lastname: Martin
authors.forename: Peter
authors.initials: P
authors.lastname: Kirkpatrick
mesh_terms: D052157:Aptamers, Nucleotide; D004311:Double-Blind Method; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy* / Q000517:prevention & control; D009841:Oligonucleotides / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000187:drug effects
chemical_list: D052157:Aptamers, Nucleotide; D009841:Oligonucleotides; D042461:Vascular Endothelial Growth Factor A; C495058:pegaptanib